Meta-analysis: Methods, strengths, weaknesses, and political uses
A critical examination of meta-analysis studies by John H. Noble, Jr, Ph.D, AHRP Treasurer
Institute of Medicine Committee: FDA drug label “is irrelevant”
"It’s not a question of just knowing the risks and it’s not a question of labeling against risk. The question is how do you change behavior?"
FDA warns diet drugs contain Prozac and Librium
Pharmaceutical News reports that the FDA has issued warnings about diet pills from Brazil marketed as dietary supplements, that contain Prozac and Librium.
S. Finance Committee Investigates Drug Makers Over Medical Education Grants_NYT
The Senate Finance committee is cracking down on drug industry "educational grants" to physicians, medical associations and "patient advocacy" groups.
ACNP Task Force Ties to Pharma
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
FDA SSRI Warning
" A causal role for antidepressants in inducing suicidality has been established in pediatric patients."
NIMH-funded antidepression drug efficacy / safety studies_What do they prove?
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
National Plan for Universal Mental Health Screening:A Pharma Friendly Remedy for Societal Problems
Download the complete powerpoint presentation
Text of power point presentation:
Slide 2: I’ll begin with the President’s New Freedom Commission on Mental Health[1] recommendation to screen the US population for mental illness – 52 million children first. In no other democratic country has the government adopted a policy to screen the population for presumed, undetected, mental illness. The rationale behind this mind-boggling Orwellian nightmare is not improving mental health, but rather increasing life-long consumers of psychoactive drugs and to control behavior. Two NFC recommendations are designed to do just that. TeenScreen is promoted as a suicide prevention model when it in fact, increases the number of children labeled suicidal and depressed.
Depression-Serotonin: How Did So Many Smart People Get it So Wrong?_WSJ
"Serotonin and depression: A disconnect between the advertisements and the scientific literature."
"Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
Ethics, Conflict of Interest, first ever public response by David Healy, MD, to James Coyne, PhD, attack in AJOB
The Columbia lecture was originally scheduled as a debate between David Healy, MD and James Coyne, PhD. The debate did not take place, and Dr. Coyne subsequently lectured in Rutgers the following week. The lecture covered the main points Dr. Coyne makes in the e-mail below. Dr. Healy’s response follows….
AHRP Testimonies | Children Victimized | Hazards | Immoral Experiments | Psych Drugs | Vulnerable Groups
AHRP Testimonies and Presentations
AHRP Testimonies and Presentations Sep 8, 2005: AHRP Testimony: NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children July 18, 2005: Cheaper than Chimpanzees Statement by Vera Hassner Sharav before the Committee on Ethical Consideration for Revisions to DHHS Regulations on Protection of Prisoners Involved in Research July 2- 8, 2005:…